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GUEST EDITORIAL
Aberrometry: Clinical and
Research Applications
Optometry has a history of taking the lead in correcting theoptical defects of the eye. While the primary definitionof optometry has changed as the profession has expanded
its scope of practice, the secondary definition of optometry has
remained unchanged. The second definition of optometry is the use
of an optometer. The definition of optometer is any of several objec-
tive or subjective devices for measuring the refractive state of the eye.
There is no better way of measuring the refractive state of the eye
than to measure its wavefront error using state-of-the-art aberrom-
eters. State-of-the-art aberrometry opens doors for new research
and clinical applications while creating a new set of issues and
opportunities. We will briefly discuss a few in this editorial.
An Opportunity
State-of-the-art aberrometry provides detailed analysis of the opti-
cal performance of refractive corrections. That is, it provides a sensitive
tool for measuring how optical aberrations of the correcting devices
combine with the subject’s own aberrations. For example: What are
the sources of optical aberrations in progressive spectacles, and soft and
rigid contact lenses? What amount of optical degradation is induced or
reduced by different types of corneal and intraocular surgeries? The
answer to these questions provided by aberrometry will lead to an
optimization of a variety of correcting devices and procedures and to a
better customization of the individual correction.
An Issue
Aberrometry is rapidly making its way into the clinic, yet there are
many technical issues still being carefully looked at in the laboratory.
While the Hartmann-Shack aberrometer has been the most widely
adopted, other approaches are being used both in the laboratory and in
commercially available instruments. Are all aberrometers equivalent?
Are there particular types of aberrometers that are more appropriate
for a particular application? What is the ideal pupil sampling config-
uration? Are measurements affected by defocus or by wavelength?
Aberrometry measures the contribution of only one source of degra-
dation (aberrations). How do we incorporate the effects of scattering
into the optical quality, and what is the best method to measure its
contribution? Aberrometry itself is not a closed technology. New re-
search and new technology will continue to contribute to a better
understanding of the measurement and a more complete set of tools.
An Opportunity
State-of-the-art aberrometry provides necessary data for design-
ing ideal corrections for the eye. Receiving less attention is the fact
that the same aberroscopic data allow for a noninvasive micro-
scopic view into the living eye. Said differently, the optical aberra-
tions of the eye limit the view into the eye. If the eye’s aberrations
can be reduced, the view through a dilated pupil will be improved.
The confocal adaptive optics scanning laser ophthalmoscope de-
veloped by researchers under the leadership of Dr. Austin Roorda
at the University of Houston’s College of Optometry is providing
the first noninvasive real-time microscopic views of individual op-
tical sections of a patient’s retina (layer by layer). With this device
it is possible to see white corpuscles flowing in 7 micrometer cap-
illaries. Noninvasively sectioning a little deeper using a confocal
sectioning technique, individual photoreceptors on the order of 2
micrometers in cross section can be readily visualized. Imagine the
opportunities to noninvasively study the living structure of the eye
at the cellular level in its healthy and pathological states! We will
soon be monitoring, photographing, and evaluating on a micro-
scopic level new medical therapy designed to alter the natural his-
tory of diseases that affect the retina, including diabetes and high
blood pressure. As the technology becomes standardized and the
components decrease in price, such devices will quickly work their
way into numerous research and clinical environments. This new
instrumentation will significantly increase the probability of devel-
oping therapy that prevents or significantly alters the natural his-
tory of diabetic retinopathy and ocular hypertension, as well as
other blinding eye diseases.
The Issue of Calibration
If the calibration of an aberrometer is incorrect, correction de-
signs based on the measurement or any comparison to other mea-
surements from other clinics and laboratories will also be incorrect.
ANSI standards need to be developed and approved. This includes
recommendations for a set of calibrated schematic eyes to be used
to help ensure that each aberrometer is calibrated in a consistent
and accurate manner. Manufacturers need to provide to the end
user a calibration set of schematic eyes with an appropriate adapter
to properly align the schematic eyes to their particular instrument.
We are pleased to report that an ANSI Standards Committee has
been formed and has been charged with developing standards for
reporting the optical aberrations of the eye and proposing recom-
mended methods of calibration. These issues will be put to rest,
hopefully within the near future. In the mean time it is wise to
question results from clinics and labs that do not provide calibra-
tion data to insure that their aberrometer was properly calibrated.
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An Opportunity
Wavefront sensing provides the fundamental information used
in the design of a variety of ideal corrections (e.g., contact lenses,
intraocular lenses, corneal refractive surgery, inlays, etc.) and to
evaluate the success of each design in minimizing the wavefront
error of the eye. This incredible promise is the high octane fuel that
shapes, molds, and guides an expanding billion dollar industry. Yet
there are unanswered general questions that apply across ap-
proaches and numerous specific questions for each approach. Here
we list a few of the general questions needing attention.
• Aberrometers measure the monochromatic aberrations of the
eye, yet the eye operates in a polychromatic world. How do we
use the monochromatic wavefront error to best optimize poly-
chromatic performance?
• What should our goal be? Is it really to minimize all aberrations
or only selected aberrations?
• Given that it is impossible to eliminate all of the optical aberra-
tions of the eye, can we create an optimized set? If so, what is the
optimized set?
• What criterion determines the optimal far-point for any given
set of aberrations?
• How do aberrations change as the crystalline lens changes in the
accommodation process?
• How do aberrations change with reading?
• Are aberrations involved in the emmetropization process (both
in humans and animal models)?
• How do aberrations change across the visual field?
An Issue
Will a patient’s neural system be able to capitalize on the in-
creased contrast and spatial detail contained in an optimized retinal
image? It is well known that if the visual system is deprived of good
retinal imagery, the deprived eye will become amblyopic. Further,
there is a critical period early in life over which good retinal imag-
ery allows the visual system to optimize its’ performance. This fact
poses several interesting questions including:
• Will we need to provide an ideal correction early in life to
achieve the maximum optimization of visual performance?
• How age dependent are the visual gains?
• If retinal image quality is optimized late in life, will vision
improve?
• If so, how much and how long will it take?
• Are there significant advantages to having an optimal set of
aberrations such as an increased depth of focus?
• How good is good enough? Can good enough be defined?
An Issue
Assuming we can achieve ideal corrections that minimize the aber-
rations of the eye, do such corrections create a new and adverse set of
problems? That is, what risks do ideal corrections pose? For example:
• Will flash bulbs become photo-coagulators?
• Will the dot matrix of newsprint provide unacceptable
resolution?
• Will the TV dot matrix provide unacceptable resolution?
• Will photo-reactive retinal disease be increased?
• Will aliasing due to photoreceptor under-sampling be a
intolerable?
An Opportunity
Knowing the wavefront error of any optical system fundamen-
tally defines the optical quality of the system. Once known, wave-
front error can be used to calculate numerous other metrics of
optical quality each having advantages and disadvantages. The rec-
ommended standard for specifying the wavefront error of the eye is
to fit the error with a normalized Zernike expansion.1 The normal-
ized Zernike expansion parcels the error into unique building
blocks (prism, astigmatism, defocus, coma, spherical aberration,
etc.). A distinct advantage of the normalized Zernike expansion is
that coefficients for each Zernike mode specify its relative contri-
bution to the total RMS error. However, RMS wavefront error is
not highly correlated to visual performance, which is highly depen-
dent upon the distribution of the wavefront error across the pupil.
Wavefront error can be used to calculate other metrics of optical
quality that better correlate with visual performance. Many old and
new metrics are currently being investigated by several groups. It is
likely that some will be very predictive of certain visual tasks and
not as predictive of other visual tasks. It is also likely that several
will be statistically equivalent. What is needed is a set of metrics
that are predictive of a wide range of visual performance measures.
An Issue
What are the clinically viable methods for evaluating visual per-
formance with increased or decreased amounts of aberrations (in-
duced or reduced by surgery or other non-optimal corrections)?
Which of the viable methods is best suited for a busy practice?
Given that high contrast visual acuity is reasonably insensitive to
subtle changes in optical quality, are there other methods of eval-
uating visual performance as efficient to administer in the clinic (as
high contrast acuity), yet more sensitive to subtle changes in optical
quality? Does the Pelli-Robson Chart or the Regan Chart meet this
need? Does low contrast logMAR letter acuity meet this need? Are
these metrics or others that we might create more predictive of
visual satisfaction in life than high contrast acuity? Or are we chas-
ing an illusion?
Clinically viable aberrometry presents numerous opportunities
for basic and clinical research, the results of which are already
improving the vision of our patients, our view into the eye, and will
soon be improving therapy designed to alter the natural history of
blinding eye disease. It is an exciting time for visual optics.
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